Evidence map›Paper›PMID 27535681›Full record

ArticleEndocrine2016

Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance.

Julia D J Thomas, Abhishek Dattani, Filip Zemrak, Thomas Burchell, Scott A Akker, Mark Gurnell, Ashley B Grossman, L Ceri Davies, Márta Korbonits

Open access · hybridAbstract read
In one paragraph

Article in Endocrine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Julia D J ThomasDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Abhishek DattaniDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Filip ZemrakNIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Thomas BurchellNIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Scott A AkkerDepartment of Endocrinology, St Bartholomew's Hospital, London, UK.
Mark GurnellUniversity of Cambridge, Metabolic Research Laboratories, Addenbrooke's Hospital, Cambridge, UK.
Ashley B GrossmanOxford Centre for Endocrinology, Diabetes and Metabolism, University of Oxford, Oxford, UK.
L Ceri DaviesNIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Márta KorbonitsDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. m.korbonits@qmul.ac.uk.
St Bartholomew's Hospital · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GBQueen Mary University of London · GBUniversity of Cambridge · GBWilliam Harvey Research Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth hormone (GH) can profoundly influence cardiac function. While GH excess causes well-defined cardiac pathology, fewer data are available regarding the more subtle cardiac changes seen in GH deficiency (GHD). This preliminary study uses cardiac magnetic resonance imaging (CMR) to assess myocardial structure and function in GHD. Ten adult-onset GHD patients underwent CMR, before and after 6 and 12 months of GH replacement. They were compared to 10 age-matched healthy controls and sex-matched healthy controls. Left ventricular (LV) mass index (LVMi) increased with 1 year of GH replacement (53.8 vs. 57.0 vs. 57.3 g/m

Indexed as

AdultAgedAortaCase-Control StudiesFemaleFibrosisGadoliniumGrowth HormoneHeartHeart VentriclesHumansInsulin-Like Growth Factor IMagnetic Resonance ImagingMaleMiddle AgedMyocardial Perfusion ImagingGadoliniumGrowth HormoneIGF1 protein, humanInsulin-Like Growth Factor I

Identifiers

PMID27535681
PMCPMC5107200
OpenAlexW2509697967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.